Prevalence of aspirin resistance measured by PFA-100
Authors:
- Isabel Coma-CanellaICIsabel Coma-Canella
- Amelia VelascoAVAmelia Velasco
- Sara CastanoSCSara Castano
- 1 May 2005
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 101 (1) , 71-76
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Antiplatelet Effect of Aspirin in Patients With Cerebrovascular DiseaseStroke, 2004
- Resistance in vitro to low-dose aspirin is associated with platelet PlA1(GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ibα) polymorphismsJACC, 2003
- Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass SurgeryCirculation, 2003
- Increased Thrombosis After Arterial Injury in Human C-Reactive Protein–Transgenic MiceCirculation, 2003
- 2008 Aspirin resistance in patients with acute myocardial infarction: is it of any clinical importance?European Heart Journal, 2003
- Low High-Density Lipoprotein CholesterolDrugs, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Standardization of the PFA‐100® platelet function test in 105 mmol/l buffered citrate: effect of gender, smoking, and oral contraceptivesBritish Journal of Haematology, 1999
- Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.The American Journal of Cardiology, 1999
- Development of aspirin resistance in persons with previous ischemic stroke.Stroke, 1994